A Swiss and a Miss: The Future of Swiss-style Patents in Singapore

In the recently-decided case of Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd[2017] SGCA 45, the Court of Appeal (“CA”) addressed a number of novel issues in Singapore patent law. The dispute between the two pharmaceutical companies was based on Novartis’ potential infringement of Warner-Lambert’s patent. This patent (filed in 1997) claimed a monopoly over the use of a substance, pregabalin, for the treatment of pain (the “Patent”).